Pulmatrix, Inc. (PULM) SEC Filing 8-K Material Event for the period ending Friday, September 27, 2019

Pulmatrix, Inc.

CIK: 1574235 Ticker: PULM

View differences made from one to another to evaluate Pulmatrix, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Pulmatrix, Inc..


Assess how Pulmatrix, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Pulmatrix, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


Ticker: PULM
CIK: 1574235
Form Type: 8-K Corporate News
Accession Number: 0001193125-19-261729
Submitted to the SEC: Thu Oct 03 2019 5:00:59 PM EST
Accepted by the SEC: Thu Oct 03 2019
Period: Friday, September 27, 2019
Industry: Pharmaceutical Preparations
  1. Event for Officers

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: